'Modest' Erectile Dysfunction Benefit With GLP-1 Agonist Dulaglutide didn't improve pre-existing symptoms, but did prevent some new cases Jun 23, 2021
Gender-Affirming Surgical Fellowships Gaining Steam in the U.S. Since 2017, number of programs offering multidisciplinary training has grown from one to eight Jun 21, 2021
Hopeful Dads Can Relax About COVID Vax: No Link to Infertility The real threat to male sexual health is COVID-19 itself, says study author Jun 17, 2021
AI for Radiation Therapy Works, but Is it Fully Trusted? Most machine learning-generated plans selected over human plans in head-to-head comparison Jun 16, 2021
What's Guiding Prostate Cancer Care for Gay Men? Research specific to this group has only scratched the surface Jun 16, 2021
Why Branded Viagra Is Vastly More Expensive Than Its Generics For some brand-name drugs, prices don't go down when generics crop up; Viagra still an outlier Jun 15, 2021
COVID Vaccine Protection; 'Until You Die From the Cancer'; What's Palliative Care? News, features, and commentary about cancer-related issues Jun 10, 2021
Promising Early Data for Bladder-Sparing Cancer Treatment Bladder-intact DFS at 1 year nears 90% for muscle-invasive bladder cancer Jun 09, 2021
New Standard for Metastatic Castration-Sensitive Prostate Cancer? Triplet regimen reduced the risk for radiographic progression or death, but OS data await Jun 09, 2021
BPAs Cut Fracture Risk in Metastatic Prostate Cancer Those receiving enzalutamide with and without radium-223 saw benefits in updated safety analysis Jun 08, 2021
Radioligand Therapy Boosts Survival in Metastatic CRPC PSMA-directed agent improved overall survival by median 4 months Jun 04, 2021
With Supplements, ADT in Prostate Cancer of Little Threat to Bone Density Study suggests calcium/vitamin D alone sufficient for long-duration therapy Jun 03, 2021
'A Quantum Leap Forward': Potential New Standard in High-Risk RCC Adjuvant immunotherapy led to 32% reduction in the risk of recurrence, positive trend in OS Jun 03, 2021
First-Line Chemo Plus Immunotherapy Falls Short in Bladder Cancer Adding pembrolizumab to cisplatin-based chemotherapy did not improve survival outcomes Jun 02, 2021
Bevacizumab Misses Mark in Untreated Metastatic Bladder Cancer No improvement in overall survival when added to cisplatin-containing chemotherapy Jun 01, 2021
Vaccination, Screening Succeeds in Cervical and Prostate Cancers Cervical cancer rates on the decline; PSA testing benefits younger Black men May 19, 2021
SBRT Safe for Cancer Patients With Multiple Metastases Late adverse events in phase I trial indicate need for extended follow-up May 03, 2021
What's Behind the Mysterious Chest Pain in Bladder Cancer Patient? Cardiomyopathy risks interrupting cancer treatment, worsening prognosis May 03, 2021
Treatment Type a Non-Factor in Prostate Cancer Patients' Anxiety Researchers emphasized importance of psychological interventions as problems arise Apr 29, 2021
Late ADT a Problem in Prostate Cancer Late dosing of LHRH agonists happens too frequently, researchers report Apr 22, 2021
No More Men Need to Die From Transrectal Prostate Biopsies A movement toward transperineal biopsies Apr 21, 2021
Olympic Gold Medalist Nathan Adrian's Testicular Cancer The swimmer's diagnosis, treatment, and an "extra year" of pandemic prep for Toyko Apr 20, 2021
Could a 'Placebo' Become the Next Big ED Treatment? Over-the-counter gel, said to spur near-instant erections, is on the cusp of approval in Europe Apr 20, 2021
Another Player in Advanced Bladder Cancer Accelerated FDA approval of sacituzumab govitecan after chemo, immunotherapy Apr 14, 2021
More Benefit With Taxane for Aggressive Metastatic Prostate Cancer Higher clinical benefit rate with front-line cabazitaxel versus androgen receptor inhibitor Apr 12, 2021
Mixed Results for Immunotherapy in Metastatic Prostate Cancer Combination trial missed response endpoint but exceeded historical results Apr 11, 2021
Overactive Bladder Drug Gains Pediatric Indication Mirabegron approved to treat kids with neurogenic detrusor overactivity Mar 26, 2021
ENDO 2021 Roundup: Jatenzo Liver Data, Adrenal Insufficiency, and More Other noteworthy research presented at the Endocrine Society's annual meeting Mar 25, 2021
Choice of Erectile Dysfunction Med May Have Heart Health Implications Large observational study of PDE-5 inhibitors vs alprostadil Mar 23, 2021
Testicular Dysfunction May Persist Long After Anabolic Steroid Use "Need to treat not just as problem of testosterone deficiency but as a body-image disorder" Mar 09, 2021
UTIs Treated Inappropriately Everywhere Both uncalled-for drugs and prolonged treatment durations, large-scale review finds Feb 26, 2021
Vaginal Pessary Viable Alternative to Surgery for Weak Pelvic Floor Majority of women continued treatment for at least 5 years Feb 24, 2021
New Standard in High-Risk Muscle-Invasive Bladder Cancer? Adjuvant nivolumab improves DFS in all comers, PD-L1 population Feb 13, 2021
CCR Score Could Offer ADT-Free Path in Higher-Risk Prostate Cancer Large proportion of intermediate- to high-risk patients could avoid aggressive therapy Feb 12, 2021
Survival Boost in Bladder Cancer With Antibody-Drug Conjugate Four-month absolute improvement with enfortumab vedotin in previously treated disease Feb 12, 2021
Radionuclide Tx Wins in Third-Line Metastatic CRPC Early trial shows improved PFS, response rates versus cabazitaxel Feb 11, 2021
Hit and Miss in Castration-Resistant Prostate Cancer No OS benefit with apalutamide-abiraterone, despite improved PFS Feb 11, 2021